193 related articles for article (PubMed ID: 23852020)
1. Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.
Ho KY; Yeh TS; Huang HH; Hung KF; Chai CY; Chen WT; Tsai SM; Chang NC; Chien CY; Wang HM; Wu YJ
Int J Mol Sci; 2013 Jul; 14(7):14439-59. PubMed ID: 23852020
[TBL] [Abstract][Full Text] [Related]
2. Heat shock proteins in middle ear cholesteatoma.
Shinoda H; Huang CC
Otolaryngol Head Neck Surg; 1996 Jan; 114(1):77-83. PubMed ID: 8570255
[TBL] [Abstract][Full Text] [Related]
3. TFIIB-related factor 2 regulates glucose-regulated protein 78 expression in acquired middle ear cholesteatoma.
Sui R; Liu C; Wang N; Fan X; Han S; Zhang J; Hou L; Zhang X; Xu A
Biochem Biophys Res Commun; 2021 Feb; 540():95-100. PubMed ID: 33453679
[TBL] [Abstract][Full Text] [Related]
4. Cholesteatoma growth and proliferation: relevance with serpin B3.
Ho KY; Huang HH; Hung KF; Chen JC; Chai CY; Chen WT; Tsai SM; Chien CY; Wang HM; Wu YJ
Laryngoscope; 2012 Dec; 122(12):2818-23. PubMed ID: 23239141
[TBL] [Abstract][Full Text] [Related]
5. Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules.
Lim SO; Park SG; Yoo JH; Park YM; Kim HJ; Jang KT; Cho JW; Yoo BC; Jung GH; Park CK
World J Gastroenterol; 2005 Apr; 11(14):2072-9. PubMed ID: 15810071
[TBL] [Abstract][Full Text] [Related]
6. Evidence of prognostic relevant expression profiles of heat-shock proteins and glucose-regulated proteins in oesophageal adenocarcinomas.
Slotta-Huspenina J; Berg D; Bauer K; Wolff C; Malinowsky K; Bauer L; Drecoll E; Bettstetter M; Feith M; Walch A; Höfler H; Becker KF; Langer R
PLoS One; 2012; 7(7):e41420. PubMed ID: 22911792
[TBL] [Abstract][Full Text] [Related]
7. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis.
Szczepanski MJ; Luczak M; Olszewska E; Molinska-Glura M; Zagor M; Krzeski A; Skarzynski H; Misiak J; Dzaman K; Bilusiak M; Kopec T; Leszczynska M; Witmanowski H; Whiteside TL
J Mol Med (Berl); 2015 Mar; 93(3):305-14. PubMed ID: 25385222
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of cholesteatoma.
Kim JL; Jung HH
Acta Otolaryngol; 2004 Sep; 124(7):783-8. PubMed ID: 15370560
[TBL] [Abstract][Full Text] [Related]
11. Expression of the gap junction proteins connexin 26 and connexin 43 in human middle ear cholesteatoma.
Choung YH; Park K; Kang SO; Markov Raynov A; Ho Kim C; Choung PH
Acta Otolaryngol; 2006 Feb; 126(2):138-43. PubMed ID: 16428189
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of glucose regulated proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus.
Langer R; Feith M; Siewert JR; Wester HJ; Hoefler H
BMC Cancer; 2008 Mar; 8():70. PubMed ID: 18331622
[TBL] [Abstract][Full Text] [Related]
13. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium.
Tanaka Y; Kojima H; Miyazaki H; Koga T; Moriyama H
Laryngoscope; 1999 Jul; 109(7 Pt 1):1102-7. PubMed ID: 10401849
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of p63 and survivin in cholesteatomas.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim HJ
Acta Otolaryngol; 2009 Mar; 129(3):268-72. PubMed ID: 18615329
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Calreticulin and Annexin A2 Expression in Acquired Middle Ear Cholesteatoma by 2-DE Analysis.
Chang NC; Wu YJ; Wang LF; Chan LP; Chai CY; Chen Ms WT; Tsai SM; Chien CY; Ho KY
Ann Otol Rhinol Laryngol; 2023 Jun; 132(6):684-691. PubMed ID: 35833235
[TBL] [Abstract][Full Text] [Related]
16. Activation of the EGFR/Akt/NF-κB/cyclinD1 survival signaling pathway in human cholesteatoma epithelium.
Liu W; Yin T; Ren J; Li L; Xiao Z; Chen X; Xie D
Eur Arch Otorhinolaryngol; 2014 Feb; 271(2):265-73. PubMed ID: 23463347
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of neutrophil gelatinase-associated lipocalin in cholesteatoma.
Woo HJ; Park JC; Bae CH; Song SY; Lee HM; Kim YD
Acta Otolaryngol; 2009 Jun; 129(6):624-9. PubMed ID: 18720059
[TBL] [Abstract][Full Text] [Related]
18. Mouse lymphoma cells destined to undergo apoptosis in response to thapsigargin treatment fail to generate a calcium-mediated grp78/grp94 stress response.
McCormick TS; McColl KS; Distelhorst CW
J Biol Chem; 1997 Feb; 272(9):6087-92. PubMed ID: 9038234
[TBL] [Abstract][Full Text] [Related]
19. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
[TBL] [Abstract][Full Text] [Related]
20. Terminal differentiation and mitogen-activated protein kinase signaling in human cholesteatoma epithelium.
Huisman MA; De Heer E; Grote JJ
Otol Neurotol; 2006 Apr; 27(3):422-6. PubMed ID: 16639284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
